PRESS RELEASE
24 July 2025

Melanie Szweras And Patrick Roszell Talk AI And Health Privacy With Lexpert

SB
Smart & Biggar

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.
Recently Smart & Biggar Principals Patrick Roszell and Melanie Szweras sat down with Lexpert’s Zena Olijnyk to discuss the privacy impacts caused by the increasing use of artificial intelligence...
Canada

Recently Smart & Biggar Principals Patrick Roszell and Melanie Szweras sat down with Lexpert’s Zena Olijnyk to discuss the privacy impacts caused by the increasing use of artificial intelligence (AI) in the healthcare sector.

Melanie raised a few key privacy concerns, including the fact the someone’s “highly sensitive” health information could be improperly disclosed or misused, and whether data used in the health and life sciences sector has been properly anonymized. Of these concerns she notes “the key issue becomes the balance between the duty to protect personal health information and the ability to manage information in the healthcare system.”

Patrick discussed the touchpoints data has between acquisition and use and how parties along the way seek to impose restrictions or assert rights on how the data is used, noting “organizations are going to need to become more sophisticated about how they understand the importance of these rights, and how they contract around them.” He also noted that organizations need to understand both the technical aspects and the privacy considerations and that “technically-minded lawyers can do a lot to bring valuable guidance in connecting these dots.”

Read the full Lexpert interview.

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More